The Company is providing guidance for 2025 for the first time, including: Sales are expected to grow by more than 50% in 2025, driven by ...
Wolfe Research analyst Alexandria Hammond initiated coverage of Johnson & Johnson (JNJ) with an Outperform rating and $190 price target ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback